Securely storing and interpreting the genome

by Cécilia Carron

At a time when sequencing the genome is becoming democratized, questions have arisen about the interpretation of these data and their secure storage. Sophia Genetics, an EPFL Science Park start-up, specializes in this. The company recently raised 2.8 million francs.

Complete sequencing of the genome will soon enable personalized treatments. Moreover, new based on are coming on the market. Given the drastic reduction on the cost of , it may even be possible before long to know each person's predisposition to certain diseases, allergies, and food intolerances. Riding on this wave in medicine, Jurgi Camblong, Pierre Hutter and Lars Steinmetz have founded a start-up to securely store this data, which promises to be considerable (one genome contains 3 billion letters or !). Reading the data will be made easier with new software.

This video is not supported by your browser at this time.

Launched in September 2012, this new bioinformatics tool is already being used by a dozen hospitals and laboratories in Switzerland. With it, a DNA sample can be taken during a and sent to a specialized laboratory for extraction. The young company based at the Ecublens Science Park has raised 2.8 million francs for development.

View a patient's DNA in the blink of an eye

Once sequenced, the data is transmitted to Sophia Genetics for bioinformatics analysis. The then has access to a to help interpret the data. Other applications for viewing and performing electronic biopsies of all parts of the genome are currently being developed.

How is it possible to ensure that a person's will not be disclosed, for example to insurance companies and employers? The company has worked to standardize and automate the analysis and storage of data in two data centers in Switzerland. With the laboratory of Professor Jean-Pierre Hubaux at EPFL, the start-up is developing a high security storage that may be necessary in the future. One of the main elements of confidentiality is to provide the patient with a cryptographic key that comes in two parts for each sequencing. The patient would give one part to Sophia Genetics and the other to the physician so that the data could only be read when the patient has given consent.

Sophia Genetics aims high: to cover 80% of the Swiss market in the field of diagnostics by the end of the year and then extend to the European market, which could reach 500 million francs by 2015. Jurgi Camblong believes that users have a vested interest in having a web host and a common software in order to standardize laboratory procedures.

add to favorites email to friend print save as pdf

Related Stories

The '$1,000 genome' may cost $100,000 to understand

May 11, 2011

Advances in technology have almost lifted the curtain on the long-awaited era of the "$1,000 genome" — a time when all the genes that make up a person can be deciphered for about that amount – compared to nearly ...

Future of personalized cancer care is promising and near

Apr 19, 2011

Cancer survival rates could improve soon with whole-genome sequencing, according to two studies published in the April 20, 2011, issue of the Journal of the American Medical Association that describe the first clinical applic ...

Science of genome-sequencing marks 10 years

Apr 15, 2013

A decade after completion of the Human Genome Project on April 14, 2003, a top official of the National Institutes of Health surveyed the rarefied view from that mountaintop:

Recommended for you

Gene clues to glaucoma risk

18 hours ago

Scientists on Sunday said they had identified six genetic variants linked to glaucoma, a discovery that should help earlier diagnosis and better treatment for this often-debilitating eye disease.

Mutation disables innate immune system

Aug 29, 2014

A Ludwig Maximilian University of Munich team has shown that defects in the JAGN1 gene inhibit the function of a specific type of white blood cells, and account for a rare congenital immune deficiency that ...

Study identifies genetic change in autism-related gene

Aug 28, 2014

A new study from Bradley Hospital has identified a genetic change in a recently identified autism-associated gene, which may provide further insight into the causes of autism. The study, now published online in the Journal of ...

NIH issues finalized policy on genomic data sharing

Aug 27, 2014

The National Institutes of Health has issued a final NIH Genomic Data Sharing (GDS) policy to promote data sharing as a way to speed the translation of data into knowledge, products and procedures that improve health while ...

User comments